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Background. An experimental approach for improving vaccine efficacy involves targeting antigens to mannose receptors
(MRs) on dendritic cells (DCs) and other professional antigen presenting cells. Previously, we demonstrated that mannosylated
Pichia pastoris-derived recombinant proteins exhibited increased immunogenicity compared to proteins lacking mannosyla-
tion. In order to gain insight into the mechanisms responsible for this observation, the present study examined the cellular
uptake of the mannosylated and deglycosylated recombinant proteins. Methodology/Principal Findings. Utilizing
transfected cell lines, roles for the macrophage mannose receptor (MMR, CD206) and DC-SIGN (CD209) in the recognition of
the mannosylated, but not deglycosylated, antigens were demonstrated. The uptake of mannosylated antigens into murine
bone marrow-derived DCs (BMDCs) was inhibited by yeast mannans (YMs), suggesting a mannose-specific C-type lectin
receptor-dependent process, while the uptake of deglycosylated antigens remained unaffected. In particular, antigens with
both N-linked and extensive O-linked mannosylation showed the highest binding and uptake by BMDCs. Finally, confocal
microscopy studies revealed that both mannosylated and deglycosylated P. pastoris-derived recombinant proteins localized in
MHC class II+ compartments within BMDCs. Conclusions/Significance. Taken together with our previous results, these data
suggest that increased uptake by mannose-specific C-type lectin receptors is the major mechanism responsible for the
enhanced antigenicity seen with mannosylated proteins. These findings have important implications for vaccine design and
contribute to our understanding of how glycosylation affects the immune response to eukaryotic pathogens.
Citation: Lam JS, Huang H, Levitz SM (2007) Effect of Differential N-linked and O-linked Mannosylation on Recognition of Fungal Antigens by
Dendritic Cells. PLoS ONE 2(10): e1009. doi:10.1371/journal.pone.0001009
INTRODUCTION
Mannosylated antigens have been demonstrated to enhance MHC
class I- and MHC class II-restricted antigen presentation, increase T
cell proliferation, and promote T cell effector responses [1–3]. Such
immune consequences have been attributed to the ability of
particular C-type lectin receptors (CLRs) to bind and endocytose
mannose-containing compounds [4]. These mannose-specific CLRs
share the ability to recognize mannose residues but differ in their
mannose binding affinities depending on the spatial configurations of
mannose. Furthermore, different CLRs may traffic their cargo
through different intracellular routes [5–7] but all typically result in
presentation of antigen in surface MHC molecules, leading to
antigen-specific T cell proliferation [5,8,9]. As mannose-specific
CLRs are highly expressed on DCs [10] and recognize mannosy-
lated ligands, they have become the target of vaccine strategies for
eliciting antigen-specific cell-mediated immune responses.
DCs are professional antigen presenting cells that play an
integral role in governing immune responses [11,12]. Two
significant methods of antigen capture by immature DCs are
macropinocytosis and endocytosis that is mediated by receptors,
including mannose-specific CLRs [13]. Macropinocytosis is
a constitutive process in immature DCs that involves non-selective
fluid phase uptake of large vesicles approximately 0.5 to 3 mM in
size [13–15]. In comparison, MMR-mediated endocytosis selec-
tively and efficiently captures mannosylated antigens [13]. Both
mechanisms of antigen capture result in delivery to MHC class II
compartments [13,15,16] but antigen internalized via mannose-
specific CLRs are significantly more potent at augmenting in vitro
T cell proliferation [1,2,17,18].
Previously, we generated a panel of recombinant mannosylated
proteins (summarized in Table 1) using the yeast P. pastoris [18].
The target antigen included in all constructs was a segment of
OVA (aa 230–359) containing epitopes recognized by both CD4+
and CD8+ T cells. Two asparagines situated in the consensus
motif Asn-X-Ser/Thr (where X denotes any amino acid except for
proline) provided potential sites for N-linked glycans while a Ser/
Thr-rich region from a cryptococcal mannoprotein designated
MP98 [19] supplied sites for extensive O-linked mannosylation.
For example, recombinant protein ppOVAST contained two Asn-
X-Ser/Thr motifs and a Ser/Thr-rich region and therefore
displayed N-linked and O-linked mannosylation. In contrast, the
sequence for ppOVA only included the Asn-X-Ser/Thr motifs.
Consequently, the recombinant protein ppOVA was found to
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exhibit mostly N-linked mannosylation and minimal O-linked
glycosylation. To examine the immunostimulatory effects caused
by N-linked mannosylation, we removed the sites for N-linked
glycosylation using site-directed mutagenesis. This resulted in the
production of recombinant proteins that lacked N-linked manno-
sylation but still contained O-linked glycosylation. Recombinant
protein ppOVASTNQ displayed extensive O-linked mannosyla-
tion while ppOVANQ harbored minimal O-mannosylation.
We found that all the P. pastoris-derived mannosylated recom-
binant proteins were more potent than the deglycosylated
recombinant proteins in eliciting antigen-specific CD4+ and
CD8+ T cell proliferation [18,20]. Interestingly, the presence of
O-linked mannosylation enhanced CD8+ T cell proliferation
while N-linked mannosylation dampened these responses. How-
ever, this effect was not seen when examining CD4+ T cell
responses as the presence of both N- and O-mannosylation
correlated with increased CD4+ T cell proliferation. Mannose-
specific CLRs appeared to play a role in inducing these elevated T
cell responses as yeast mannans (YMs) inhibited CD4+ T cell
proliferation. In the present study, we explored the mechanism(s)
responsible for the enhanced immunogenicity of the mannosylated
antigens. We hypothesized that the increased immunogenic
properties of mannosylated P. pastoris-derived recombinant OVA
proteins was due to the increased mannose-specific CLR-mediated
uptake of these antigens into DCs and their subsequent trafficking
into MHC class II-enriched compartments.
RESULTS
Mannose-specific C-type lectin receptor binding
specificities for differentially mannosylated
recombinant OVA proteins
Our previous results suggested that the heightened antigen-specific
T cell responses induced by differentially mannosylated P. pastoris-
derived recombinant proteins were due to a mannose-specific
CLR-dependent endocytic process [18]. Therefore, we sought to
determine whether the mannosylated OVA antigens were capable
of being specifically recognized by two major CLRs, MMR and
DC-SIGN. Stably transfected cell lines expressing the MMR or
DC-SIGN were incubated with Oregon Green 488 (OG)-labeled
recombinant OVA antigens in the presence or absence of YMs.
YMs consist of branched chains of mannose which bind mannose-
specific CLRs, including the MMR [13] and DC-SIGN [5]. The
concentration of YM used, 1 mg/ml, has been shown to
profoundly inhibit MR [21]. Subsequent antigen binding and
uptake were measured using flow cytometry. Comparative analysis
of bound antigen to CHO cells expressing the MMR (CHO-
MMR) and untransfected CHO-K1 controls revealed binding was
strongest with ppOVAST, followed by ppOVA and ppO-
VASTNQ (Fig. 1). These interactions were specific as YMs were
able to inhibit binding of all three aforementioned proteins (Fig. 1).
In contrast, the MMR exhibited minimal to no binding to
ppOVANQ, ppOVAST dg, and the endocytosis control BSA
(Fig. 1). Comparison of the amount of bound antigen on K562
cells expressing DC-SIGN and untransfected K562 WT counter-
parts showed that DC-SIGN strongly bound ppOVAST and
modestly bound ppOVASTNQ and ppOVANQ (Fig. 2). Surpris-
ingly, ppOVA was not bound by DC-SIGN to any appreciable
extent (Fig. 2). Similar to the MMR, DC-SIGN did not specifically
bind to ppOVAST dg and BSA (Fig. 2). Altogether, these data
suggest that optimal recognition of the recombinant proteins by
MMR requires the presence of both N-mannosylation and
extensive O-mannosylation while DC-SIGN relies primarily on
O-mannosylation. Interestingly, cells transfected with MMR, but
not DC-SIGN, had increased uptake of ppOVA.
To ascertain that the above effects were specific for CLRs with
mannose-binding activity, control experiments were performed
using NIH 3T3 cells stably transfected with dectin-1 [22]. Dectin-
1 is a CLR which binds fungal b-glucans but not mannose [23].
Dectin-1-transfected and untransfected NIH 3T3 cells were in-
cubated with the panel of OG-labeled antigens. Cell-associated
fluorescence, as measured by flow cytometry, was nearly identical
when comparing transfected and untransfected cells. Moreover,
there were no significant differences amongst the individual antigen
preparations, and cell-associated fluorescence was not inhibited by
mannan or the dectin-1 inhibitor, laminarin (data not shown).
Role of surface mannose-specific C-type lectin
receptors in the uptake of mannosylated
recombinant OVA proteins on dendritic cells
We next evaluated whether DCs, which highly express both MMR
and DC-SIGN [24], would differentially bind and internalize the
recombinant OVA proteins. BMDCs were pulsed with OG-
labeled recombinant OVA proteins for varying lengths of time and
cell-associated fluorescence was analyzed by flow cytometry. As
expected, binding and uptake of all proteins, as determined by an
increase in fluorescence, increased as a function of time. However,
BMDCs showed the greatest binding and/or internalization for
the mannosylated recombinant OVA proteins when compared to
the deglycosylated OVA antigens (Fig. 3). Moreover, as with the
transfected cell lines, the greatest cell-associated fluorescence was
observed with ppOVAST. Uptake of the macropinocytosis
marker, Lucifer yellow, was similar to that of ppOVAST dg (data
not shown), suggesting that ppOVAST dg is not recognized by
receptor-dependent processes. To discern whether the enhanced
uptake of the mannosylated OVA antigens was a mannose-specific
CLR-dependent process, BMDCs were pulsed with OG-labeled
Table 1. P. pastoris-derived recombinant proteins utilized in the study
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Recombinant Protein Components Molecular Size (Unglycosylated) (Daltons) Mannosylation Profile
ppOVA OVA-cMyc-6XHis 17,169 N-links and minimal O-links
ppOVANQ OVA*-cMyc-6XHis 17,197 Minimal O-links
ppOVAST OVA-S/T rich-region-cMyc-6XHis 22,155 N-links and extensive O-links
ppOVASTNQ OVA*-S/T rich-region-cMyc-6XHis 22,183 Extensive O-links
ppOVAST dg** OVA-S/T rich-region-cMyc-6XHis 22,155 None
More details regarding the proteins, including schematics of glycosylation sites and representative gels, can be found in reference [18].
*Two asparagine (N) residues in the OVA portion were mutagenized to two glutamine (Q) residues, thus preventing formation of N-linked glycans.
**P. pastoris-produced ppOVAST was subjected to chemical deglycosylation using TFMS.
doi:10.1371/journal.pone.0001009.t001..
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Figure 1. The macrophage mannose receptor recognizes P. pastoris-
derived mannosylated antigens but not deglycosylated antigens.
CHO-K1 and CHO-MMR cell lines were pulsed with OG-labeled antigens
(each containing 2000 relative fluorescence units (RFU)) for 20 min in
the absence or presence of YMs (1 mg/ml). Cells were harvested and
analyzed for antigen binding on CHOK1 and CHO-MMR cells by flow
cytometry. The CHO-MMR cells were gated on MMR+ cells by staining
with PE-labeled antibodies to MMR. OG-labeled BSA served as a control
for background uptake by endocytosis. Background staining of cells is
indicated by the shaded histogram. Results are representative of 2
independent experiments.
doi:10.1371/journal.pone.0001009.g001
Figure 2. DC-SIGN recognizes P. pastoris-derived mannosylated
antigens but not deglycosylated antigens. K562 WT and K562 DC-
SIGN cell lines were studied under identical conditions as in figure 1.
Results are representative of 2 independent experiments.
doi:10.1371/journal.pone.0001009.g002
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recombinant OVA antigens in the presence or absence of YMs for
90 min (Fig. 4). We observed that all the mannosylated recom-
binant OVA antigens showed a substantial amount of cell-associated
fluorescence after 90 min which was inhibited by the addition of
YMs. Another antagonist of mannose-specific CLRs, a-methyl-D-
mannopyranoside (100 mg/ml) [17] inhibited cell-associated fluo-
rescence to a similar extent as did YMs, whereas the carbohydrates,
N-acetyl-D-glucosamine (1 mg/ml), dextran T500 (100 mg/ml), and
barley powder b-glucans (100 mg/ml) did not (data not shown).
Surface antigen binding and/or uptake of pOVAST dg was not
affected by any of the putative inhibitors including YMs.
The inhibitory activity of YMs on mannosylated recombinant
OVA antigen uptake suggested that MRs played a predominant
role in antigen internalization. To confirm that receptors were
responsible for the antigen uptake and to rule out any non-specific
inhibitory effects of YMs, BMDCs were pulsed with fluorescent
OG-labeled antigens in the presence or absence of excess amounts
of the same unlabeled recombinant OVA antigens. As would be
expected of a receptor-mediated process, binding and/or uptake of
fluorescently-labeled ppOVAST was inhibited by unlabeled
ppOVAST to levels approaching background (Fig. 5). Unlike
ppOVAST, ppOVAST dg is presumably internalized by a macro-
pinocytic, rather than a receptor-mediated process, and therefore
binding and/or internalization was not decreased by excess
unlabeled ppOVAST dg. In fact, a slight enhancement in uptake
was observed. Altogether, our results suggest that DCs specifically
bind and internalize the mannosylated, but not the deglycosylated,
recombinant OVA proteins using mannose-specific CLRs. Fur-
thermore, DCs appear to have disparate binding affinities for the
different mannosylated OVA antigens.
Colocalization of recombinant OVA proteins and
MHC class II molecules in DCs
The finding that mannose-specific CLRs are involved in the
uptake of mannosylated OVA antigens but not deglycosylated
OVA antigens led us to consider that antigens might be sorted into
distinct intracellular compartments according to their mannosyla-
tion status. In the final set of experiments, BMDCs, acquired from
transgenic mice expressing MHC class II molecules (I-Ab) tagged
with enhanced green fluorescent protein (MHC II-eGFP) [25],
were incubated with fluorescently labeled-recombinant OVA
proteins and their subsequent intracellular fates were visualized
by confocal microscopy. All the recombinant OVA proteins,
including the deglycosylated versions, were found to localize in
MHC II-positive compartments (Fig 6).
DISCUSSION
The data presented begin to address the mechanistic basis for the
observation that fungal mannosylation enhances antigen immu-
nogenicity [17,18,20,26]. We focused upon the mannose-specific
CLRs responsible for antigen uptake, the relative roles of N- and
O-linked mannosylation, and the intracellular localization of the
differentially mannosylated antigens.
Cell lines stably transfected with either MMR or DC-SIGN
were used to evaluate the recognition of the differentially
mannosylated OVA antigens by mannose-specific CLRs. We
found that DC-SIGN and the MMR had the highest binding for
ppOVAST, the antigen with both N-linked and extensive O-
linked mannosylation. ppOVASTNQ, which contains extensive
O-linked mannosylation, but no N-linkages, was recognized by
both MMR and DC-SIGN, but with lesser binding compared to
that seen with ppOVAST. In contrast, ppOVA bound to MMR
but not DC-SIGN. Thus, O-mannosylation of antigen seems
critical for optimal DC-SIGN binding whereas either N- or O-
mannosylation of antigen appears able to act as a ligand for MMR
Figure 4. YMs inhibit surface binding and/or internalization of P. pastoris-derived mannosylated antigens but not deglycosylated antigens by
murine BMDCs. Murine BMDCs (day 9) were pulsed with 2000 RFU of the indicated OG-labeled antigens for 90 min in the presence (dashed line
histogram) or absence (heavy line histogram) of YMs (1 mg/ml). Cells were harvested, stained for CD11c-PE, and antigen uptake analyzed by flow
cytometry. Histograms are gated on CD11c+ cells. Background staining of cells is indicated by the shaded histogram. Results are representative of 2
independent experiments.
doi:10.1371/journal.pone.0001009.g004
Figure 3. Recombinant OVA antigen uptake by DCs over time.Murine
BMDCs were pulsed with OG-labeled antigens (each containing 2000
RFU) for 22.5, 45, or 90 min. Cells were washed, stained with CD11c-PE,
and analyzed by flow cytometry. The MFI is represented by the
geometric mean of the gated CD11c+ peak. Data represent the mean6
SEM of four independent experiments. Data were analyzed using the
one-way ANOVA and Tukey’s HSD post hoc test (a=0.05). A significant
increase in cell-associated fluorescence for ppOVAST was observed
when compared to ppOVAST dg at all time points.
doi:10.1371/journal.pone.0001009.g003
DC Uptake of Mannosylated Ag
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binding. These findings were unanticipated because DC-SIGN is
thought to have affinity for the type of branched high-mannose N-
glycans produced by P. pastoris. Although DC-SIGN harbors only
one carbohydrate recognition domain (CRD), DC-SIGN exists as
a tetramer due to interactions of the neck domains [27]. This
tetramer formation is presumed to allow binding of closely spaced
glycans such as those present in N-linked high mannose
oligosaccharides [27]. In contrast, the MMR is thought to exist
in a single polypeptide extended formation [28] and therefore
predisposes the CRDs to favor a linear arrangement of mannose
residues [29,30], such as those found in fungal O-linked glycans.
As fungal O-linked oligosaccharides are generally short in length
and unbranched [31], they were predicted to be better candidates
for binding MMR compared with DC-SIGN. In addition, the
amount of O-linked oligosaccharides may help increase the MMR
affinity for the protein.
In our system, DCs were utilized as the APC for presentation of
the recombinant mannosylated OVA antigens and were found to
induce OVA-specific transgenic CD4+ T cell proliferation in
a mannose-specific CLR-dependent manner [18]. Moreover, DCs
have been identified as the major APC responsible for stimulating
proliferation of cryptococcal mannoprotein-specific T cells and
appear to be adept at mannosylated antigen capture via the MMR
and DC-SIGN [26]. Thus, the surface expression of multiple types
of mannose-specific CLRs on DCs combined with the ability of
both DC-SIGN and the MMR to recognize our panel of
recombinant mannosylated proteins (Fig. 2) suggest a redundancy
in mannosylated antigen specificities among different CLRs.
These findings help explain why no significant differences in
CD4+ T cell proliferation were observed when T cells were
incubated with wild-type or MMR knock-out DCs pulsed with
mannosylated OVA antigens [18]. Herein, we directed our studies
to specifically examine DC binding and internalization of the
recombinant OVA antigens. We found that the mannosylated
recombinant OVA antigens were efficiently internalized into DCs
in a mannose-specific CLR-dependent manner.
The confocal microscopy data suggest that, once internalized,
the mannosylated and deglycosylated recombinant OVA proteins
traffic into MHC class II-containing compartments. The question
then arises as to why the mannosylated antigens are so much more
potent at stimulating T cell responses. Certainly, the enhanced
uptake of the mannosylated antigens provides at least a partial
explanation although other factors such as more efficient pro-
cessing and presentation could also be contributing. Interestingly,
stimulation of BMDCs with the mannosylated antigen, ppOVA,
did not stimulate production of the cytokines TNFa and IL-12p70
[20]. Others have also found that while both mannose-conjugated
and unmannosylated antigens colocalize with MHC class II
molecules, the mannose-conjugated antigens were profoundly
more potent at stimulating in vitro T cell proliferation [1,2].
Although both are eukaryotes, a significant difference between
fungi and mammals is the extensive use of protein mannosylation
in the fungal kingdom. Fungal mannosylation is viewed by the
mammalian immune system as a pathogen-associated molecular
pattern. However, the nature of the immune response that occurs
following ligation of mannose-specific CLRs by fungal mannose
groups is still being defined. Our data suggesting that recognition
by CLRs of N-linked and O-linked fungal mannose differs has
important implications for the design of vaccines that target DC
via their mannose-specific CLRs. Studies characterizing the type
of immune response induced by the mannosylated recombinant
OVA proteins in vivo are planned and should provide additional
insights for the optimal development of mannosylated antigens as
vaccines.
MATERIALS AND METHODS
Materials and cell culture reagents
All chemical and cell culture reagents were obtained from Sigma-
Aldrich (St. Louis, MO) and Invitrogen Life Technologies
(Carlsbad, CA), respectively, unless otherwise stated. BMDC
media consisted of RPMI 1640, 10% FBS (Tissue Culture
Biologicals, Tulare, CA), 100 U/mL penicillin, 100 mg/mL
streptomycin, 2 mM L-glutamine, and 55 nM b-mercaptoethanol.
Cell line media were composed of RPMI 1640 containing 10%
FBS, 100 U/ml penicillin, 100 mg/ml streptomycin, 2 mM L-
glutamine, and 10 mM HEPES buffer.
Figure 5. Effects of excess unlabeled recombinant OVA proteins on
the uptake of fluorescent-labeled recombinant OVA proteins. Murine
BMDCs were pulsed with OG-labeled antigens (each containing 2000
RFU) in the presence or absence of the same unlabeled antigen (1 mg/
ml) for 45 min. Cells were washed, stained with CD11c-PE, and analyzed
by flow cytometry. The plot labeled ‘‘Isotype control’’ represents cells
treated with no antigen and stained with an isotype control antibody
for CD11c-PE. Results are representative of 3 to 4 independent
experiments.
doi:10.1371/journal.pone.0001009.g005
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Recombinant mannosylated and unglycosylated
OVA proteins
The generation of recombinant OVA proteins was performed as
previously described [18]. Briefly, the recombinant mannosylated
OVA proteins (ppOVAST, ppOVA, ppOVASTNQ, and ppO-
VANQ) were produced using the EasySelect Pichia Expression kit
(Invitrogen Life Technologies, Carlsbad, CA). Mannosylated
recombinant OVA proteins were purified over a Ni-NTA (Qiagen,
Valencia, CA) column using fast performance liquid chromato-
graphy (AKTA model; Amersham Pharmacia Biotech, Piscat-
away, NJ). Proteins were lyophilized, resuspended in PBS, and
filter-sterilized. Chemical deglycosylation of ppOVAST was
performed using the GlycoProfile IV chemical deglycosylation
kit (Sigma-Aldrich, St. Louis, MO) as previously described.
Primary Cells Bone marrow-derived DCs (BMDCs) were
generated following the protocol of Lutz et al [32] as in our
previous studies [18]. Briefly, bone marrow was obtained from
tibiae and femurs of 8–14 week old male C57BL/6 mice. Cells
were seeded at 26106 per 100 mm bacteriological Falcon Petri
dish in 10 mLs of BMDC media supplemented with 10% GM-
CSF-containing supernatant from the J558L cell line. Cell cultures
were fed on day 3, 6, and 8 and used on day 9 or 10.
Cell lines expressing CTL receptors CHO cells stably
transfected with the MMR (CHO-MMR) and K562 cells stably
transfected with DC-SIGN (K562 DC-SIGN) (a gift from Dr. A.
Corbi, Madrid, Spain) were maintained in cell line media with
0.5 mg/ml Geneticin as in our previous studies [17,26]. NIH 3T3-
Dectin-1 [22] and the parent cell lines, NIH 3T3, CHO-K1 and
K562, were maintained in cell line media.
Mice
C57BL/6 male mice were purchased from The Jackson
Laboratory, Bar Harbor, ME. MHC II-eGFP mice were a gift
of J. Vyas and H. Ploegh, Cambridge, MA. These transgenic mice
express enhanced green fluorescent protein-tagged MHC class II
molecules [25]. Animals were housed under pathogen-free condi-
tions at the Boston University Laboratory Animal Science Center.
All animal experiments were conducted with approval by the
Boston University Institutional Animal Use and Care Committee.
Fluorescent labeling of recombinant proteins
Proteins were dialyzed against a sterile solution of 0.1 M sodium
bicarbonate buffer (pH 8.3) and adjusted to a final concentration
of 1 mg/ml. Fluorescent dyes (Oregon Green 488 (OG) or Alexa
Fluor 568 (AF568)) (Invitrogen Life Technologies, Carlsbad, CA)
were dissolved in anhydrous DMSO and added to the recombi-
nant proteins at a final concentration of 15 mg/ml. Samples were
incubated for 3 to 4 hours at room temperature or overnight at
4uC protected from light. Unreacted excess fluorescent dye was
removed by dialysis using Ultrafree Centrifugal Filter Devices with
a molecular weight cut-off membrane of 10K (Millipore, Billerica,
MA). A Tecan GENios fluorescent plate reader equipped with
Magellan software (Tecan Trading AG, Switzerland) was used to
read and analyze the relative fluorescence values obtained from
each sample. Protein concentration was assessed using the BCA
assay (Pierce). The efficiency of labeling was not significantly
affected by mannosylation (data not shown). Samples were stored
in the dark at 4uC.
Binding/Uptake Assays Using Fluorescent-Labeled
Proteins
Recombinant proteins were pre-incubated with polymyxin B
(20 mg/ml) to neutralize potential endotoxin contamination.
Binding/uptake of recombinant proteins or BSA by BMDCs
was not altered by polymyxin B (data not shown). BMDCs (day 9
or 10) or cell lines (CHO-K1, CHO-MMR, K562, K562-DC-
Figure 6. Colocalization of recombinant OVA proteins with MHC class II in murine BMDCs. MHC II-eGFP BMDCs were incubated with AF568
labeled-recombinant OVA protein (2mM) for 10 min. The live cells were then washed and kept on ice until imaging by confocal microscopy. Bar
denotes 10 mM scale. Upper left: brightfield images. Upper right: red channel images demonstrating recombinant OVA proteins; Lower left: green
channel images demonstrating MHC class II; Lower right: Merge images. Yellow pseudocolor indicates colocalization of recombinant OVA proteins
and MHC class II. (a) ppOVAST, (b) ppOVA, (c) ppOVASTNQ, (d) ppOVANQ, (e) ppOVAST dg.
doi:10.1371/journal.pone.0001009.g006
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SIGN, NIH 3T3, NIH 3T3-Dectin-1) were then incubated with
fluorescent-labeled proteins at 37uC for the indicated amounts of
time. Cells were washed 3 times with DPBS containing 2% FBS.
Samples were then stained with the desired antibody and analyzed
using flow cytometry.
Confocal Microscopy
BMDCs (day 10) were resuspended at 56105 cells/ml in BMDC
media supplemented with 10% GM-CSF containing supernatant
from the J558L cell line and plated at 66104 cells in glass-bottom
confocal dishes (MatTek, Ashland, MA). DCs were allowed to
adhere overnight. Fluorescent-labeled antigens mixed with poly-
myxin B (at a final concentration of 20 mg/ml) were added to the
DCs for 10 minutes. Cells were gently washed 3 times with ice
cold BMDC media and kept on ice until confocal imaging. DCs
were then visualized using a Zeiss inverted LSM 510 confocal laser
scanning microscope equipped with an argon and two helium-
neon lasers. Confocal images were analyzed using Zeiss LSM510
software.
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